Vertex Pharmaceuticals Inc
VRTX· Nasdaq
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $714.72M | $398.08M | $138.51M | $118.45M |
| Net Income | $247.76M | -$41.63M | -$198.61M | -$232.46M |
| EPS Diluted | $0.99 |
Vertex Pharmaceuticals Inc · CIK 875320 · Engraved from SEC EDGAR
| -$0.17 |
| -$0.83 |
| -$1.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.